» Articles » PMID: 2318008

Prediction of Drug Distribution into Human Milk from Physicochemical Characteristics

Overview
Specialty Pharmacology
Date 1990 Feb 1
PMID 2318008
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Decisions about the safety of breast feeding during maternal ingestion of drugs require knowledge of the amount of drug which might be present in the milk. For many drugs this has not been studied, and mothers are usually advised against breast feeding. In many cases this is undoubtedly unnecessary, as the total dose to which the baby is exposed is often negligible. It would be very helpful, therefore, to be able to predict the approximate amount of drug which might be present in milk. Existing theory of pH partitioning enables estimation of the distribution of unbound drug, i.e. milk: plasma unbound ratios. However, these ratios are poor estimates of the concentration ratios for whole milk, because whole milk contains proteins and lipid in which drugs will distribute in amounts which depend on their particular physicochemical properties. To predict the milk: plasma concentration ratios for whole milk the amount of drug present in the protein and lipid phases must be considered along with the unbound drug distribution. A 'phase distribution model' has therefore been developed which permits estimation of whole milk: plasma concentration ratios. The model requires a knowledge of the unbound drug concentration ratio, the plasma and milk unbound fractions and the milk lipid: ultrafiltrate partition coefficient. Evaluation of the model by comparison of predicted whole milk ratio values with literature milk: plasma area under the curve (AUC) ratios indicated a trend to overprediction for acidic and neutral drugs and underprediction for basic drugs. Transformation of the phase distribution equation by taking logarithms results in a relationship which can be analysed by multiple linear regression to derive predictive equations for acidic and basic drugs which take into account the relative contributions of each component of the model. Regression of the logarithms of the literature milk: plasma AUC values against the independent variables resulted in good correlations for acidic and basic drugs. The independent variables explained 93.1% and 82.9% of the variance in the values for acidic and basic drugs, respectively, with random scatter of residuals. The equations, together with those to predict unbound fractions of drug in milk and milk lipid: ultrafiltrate partition coefficients, enable the ratio of the milk: plasma AUCs to be estimated for any acidic or basic drug for which the distribution into human milk is not known, using the pKa, octanol: water partition coefficient and plasma protein binding values of the drug. The data set for neutral drugs (n = 3) was too small to develop a correlation equation.(ABSTRACT TRUNCATED AT 400 WORDS)

Citing Articles

Clinical lactation studies. Acting on key recommendations over the last decade.

Rowland Yeo K, Gerhart J, Sawant-Basak A, Ojara F, Kawuma A, Waitt C NPJ Womens Health. 2025; 3(1):19.

PMID: 40028395 PMC: 11870844. DOI: 10.1038/s44294-025-00064-0.


Evaluation of mathematical models for predicting medicine distribution into breastmilk - considering biological heterogeneity.

Heo S, Butler A, Stamouli Simoncioni M, Moult S, Malamatari M, Kerwash E Front Pharmacol. 2024; 15:1507551.

PMID: 39679374 PMC: 11645658. DOI: 10.3389/fphar.2024.1507551.


Development and Characterization of a Human Mammary Epithelial Cell Culture Model for the Blood-Milk Barrier-A Contribution from the ConcePTION Project.

La Mantia D, Nauwelaerts N, Bernardini C, Zannoni A, Salaroli R, Lin Q Int J Mol Sci. 2024; 25(21).

PMID: 39519007 PMC: 11546117. DOI: 10.3390/ijms252111454.


Using PBPK modeling to supplement clinical data and support the safe and effective use of dolutegravir in pregnant and lactating women.

Ning J, Pansari A, Rowland Yeo K, Heikkinen A, Waitt C, Almond L CPT Pharmacometrics Syst Pharmacol. 2024; 13(11):1924-1938.

PMID: 39478302 PMC: 11578129. DOI: 10.1002/psp4.13251.


Impact of Milk pH and Fat Content on the Prediction of Milk-to-Plasma Ratio: Knowledge Gap and Considerations for Lactation Study Design and Interpretation.

Abduljalil K, Faisal M Clin Pharmacokinet. 2024; 63(11):1561-1572.

PMID: 39453598 DOI: 10.1007/s40262-024-01432-w.


References
1.
Kulas J, LUNELL N, Rosing U, Steen B, Rane A . Atenolol and metoprolol. A comparison of their excretion into human breast milk. Acta Obstet Gynecol Scand Suppl. 1984; 118:65-9. DOI: 10.3109/00016348409157126. View

2.
Findlay J, DeAngelis R, Kearney M, Welch R, Findlay J . Analgesic drugs in breast milk and plasma. Clin Pharmacol Ther. 1981; 29(5):625-33. DOI: 10.1038/clpt.1981.87. View

3.
Brogden R, Heel R . Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 1986; 31(2):96-130. DOI: 10.2165/00003495-198631020-00002. View

4.
Levin V, Dolginow D, Landahl H, Yorke C, Csejtey J . Relationship of octanol/water partition coefficient and molecular weight to cellular permeability and partitioning in s49 lymphoma cells. Pharm Res. 2013; 1(6):259-66. DOI: 10.1023/A:1016393902123. View

5.
Lewis A, Patel L, Johnston A, Turner P . Mexiletine in human blood and breast milk. Postgrad Med J. 1981; 57(671):546-7. PMC: 2426155. DOI: 10.1136/pgmj.57.671.546. View